ATE353366T1 - Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten - Google Patents

Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Info

Publication number
ATE353366T1
ATE353366T1 AT01964345T AT01964345T ATE353366T1 AT E353366 T1 ATE353366 T1 AT E353366T1 AT 01964345 T AT01964345 T AT 01964345T AT 01964345 T AT01964345 T AT 01964345T AT E353366 T1 ATE353366 T1 AT E353366T1
Authority
AT
Austria
Prior art keywords
cancer
protein
called
types
detection
Prior art date
Application number
AT01964345T
Other languages
English (en)
Inventor
Mary Faris
Rene S Hubert
Arthur B Raitano
Daniel E H Afar
Elana Levin
Pia M Challita-Eid
Aya Jakobovits
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE353366T1 publication Critical patent/ATE353366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01964345T 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten ATE353366T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22709800P 2000-08-22 2000-08-22
US28273901P 2001-04-10 2001-04-10

Publications (1)

Publication Number Publication Date
ATE353366T1 true ATE353366T1 (de) 2007-02-15

Family

ID=26921162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964345T ATE353366T1 (de) 2000-08-22 2001-08-22 Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten

Country Status (10)

Country Link
US (6) US6863892B2 (de)
EP (2) EP1311675B1 (de)
AT (1) ATE353366T1 (de)
AU (2) AU2001285210A1 (de)
CA (1) CA2420543C (de)
DE (1) DE60126495T2 (de)
DK (1) DK1854809T3 (de)
ES (2) ES2395524T3 (de)
PT (1) PT1854809E (de)
WO (2) WO2002016598A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311675B1 (de) * 2000-08-22 2007-02-07 Agensys, Inc. Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002026826A2 (en) * 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US6875570B2 (en) 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
US7223577B2 (en) * 2000-11-17 2007-05-29 Allergan, Inc. Post-translational modifications and Clostridial neurotoxins
JP2007524361A (ja) * 2003-02-10 2007-08-30 アジェンシス， インコーポレイテッド 膀胱癌及びその他の癌の治療及び検出に有用な名称１５８ｐ１ｄ７の核酸及び対応タンパク質
AU2004302745B2 (en) * 2003-08-29 2008-02-07 Samsung Electronics Co., Ltd. Apparatus and method for controlling operational states of medium access control layer in a broadband wireless access communication system
US7754223B2 (en) * 2003-10-07 2010-07-13 Eurogentec Sa Piscirickettsia salmonis antigens and use thereof
US20110171251A1 (en) * 2004-10-01 2011-07-14 Micael Thiry Piscirickettsia salmonis antigens and use thereof
AU2013200566B2 (en) * 2006-10-17 2014-10-09 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
KR101543622B1 (ko) 2006-10-17 2015-08-11 온코세라피 사이언스 가부시키가이샤 Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
US20090090696A1 (en) * 2007-10-08 2009-04-09 Cabot Microelectronics Corporation Slurries for polishing oxide and nitride with high removal rates
WO2009052376A1 (en) * 2007-10-18 2009-04-23 Musc Foundation For Research Development Methods for the diagnosis of genitourinary cancer
CA2708167C (en) * 2007-12-19 2016-11-29 David Francis Kirke Vaccine antigens from piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
US8449512B2 (en) 2010-04-09 2013-05-28 Davinci Biomedical Research Products Inc. Stoma stabilitating device and method
WO2012169911A1 (en) * 2011-06-10 2012-12-13 Auckland Uniservices Limited Peptides, constructs and uses therefor
GB201115910D0 (en) 2011-09-14 2011-10-26 Univ Manchester Peptides
TWI606063B (zh) 2012-08-23 2017-11-21 艾澤西公司 結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ）
CA2994929A1 (en) 2015-08-12 2017-02-16 Oncotherapy Science, Inc. Depdc1-derived peptide and vaccine containing same
CN108489921B (zh) * 2018-05-02 2020-08-11 天津科技大学 一种免双氧水快速检测半胱氨酸的方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33504A (en) * 1861-10-15 Improvement in nozzles for hose-pipes
US335074A (en) * 1886-01-26 jewett
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
DK0489149T3 (da) 1990-06-27 2001-12-27 Univ Princeton Prober til påvisning af mutant P53
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
US5783186A (en) * 1995-12-05 1998-07-21 Amgen Inc. Antibody-induced apoptosis
CA2252886C (en) 1996-04-26 2008-02-12 Massachusetts Institute Of Technology Three-hybrid screening assay
US5840501A (en) 1996-10-25 1998-11-24 Bayer Corporation Determination of cPSA
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20030204052A1 (en) * 2000-10-04 2003-10-30 Herrmann John L. Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
EP1194549A2 (de) 1999-07-02 2002-04-10 Chiron Corporation Menschliche gene und gen expressionsprodukte
EP1074617A3 (de) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers für Synthese von ganzen-Länge cDNS und deren Anwendung
AU2001229340A1 (en) 2000-01-14 2001-07-24 Millennium Pharmaceuticals, Inc. Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
AU2001243142A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US7534417B2 (en) * 2000-02-24 2009-05-19 Agensys, Inc. 103P2D6: tissue specific protein highly expressed in various cancers
US20060003323A1 (en) * 2000-03-01 2006-01-05 John Alsobrook Therapeutic polypeptides, nucleic acids encoding same, and methods of use
IL152416A0 (en) 2000-04-27 2003-05-29 Smithkline Beecham Corp Novel compounds
US20040033504A1 (en) * 2001-04-26 2004-02-19 Pankaj Agarwal Novel compounds
JP2004516813A (ja) * 2000-06-30 2004-06-10 インサイト・ゲノミックス・インコーポレイテッド 関連腫瘍マーカー
EP1311675B1 (de) * 2000-08-22 2007-02-07 Agensys, Inc. Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
EP1368375A2 (de) 2000-09-05 2003-12-10 Incyte Genomics, Inc. Sekretorische moleküle
ATE549347T1 (de) * 2000-09-08 2012-03-15 Schering Corp Gene von säugetiere, und damit verbundene reagentien, methoden
US6875570B2 (en) * 2000-09-27 2005-04-05 Curagen Corporation Proteins and nucleic acids encoding same
WO2002026826A2 (en) 2000-09-27 2002-04-04 Curagen Corporation Proteins and nucleic acids encoding same
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
JP2005503760A (ja) 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
US20020192678A1 (en) 2001-02-09 2002-12-19 Huei-Mei Chen Genes expressed in senescence
WO2003004989A2 (en) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20040076955A1 (en) 2001-07-03 2004-04-22 Eos Biotechnology, Inc. Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
EP1430112A4 (de) 2001-09-24 2005-06-15 Nuvelo Inc Neue nukleinsäuren und polypeptide
EP1438432A4 (de) 2001-10-22 2005-11-09 Exelixis Inc Lrrcaps als modifikatoren des p53-wegs und verwendungsverfahren

Also Published As

Publication number Publication date
CA2420543C (en) 2013-04-02
US20030017466A1 (en) 2003-01-23
PT1854809E (pt) 2012-12-26
EP1854809B1 (de) 2012-10-03
US20050227253A1 (en) 2005-10-13
AU2001286699A1 (en) 2002-03-04
US20030207835A1 (en) 2003-11-06
WO2002016593A3 (en) 2002-12-27
US6863892B2 (en) 2005-03-08
WO2002016598A2 (en) 2002-02-28
EP1311675A2 (de) 2003-05-21
EP1854809A1 (de) 2007-11-14
DE60126495T2 (de) 2007-11-29
US20060018917A1 (en) 2006-01-26
ES2395524T3 (es) 2013-02-13
AU2001285210A1 (en) 2002-03-04
EP1311675B1 (de) 2007-02-07
ES2281437T3 (es) 2007-10-01
DE60126495D1 (de) 2007-03-22
WO2002016598A3 (en) 2003-01-23
US20030166526A1 (en) 2003-09-04
CA2420543A1 (en) 2002-02-28
WO2002016593A2 (en) 2002-02-28
US20030199470A1 (en) 2003-10-23
DK1854809T3 (da) 2013-01-21
HK1110876A1 (en) 2008-07-25

Similar Documents

Publication Publication Date Title
ATE353366T1 (de) Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
IT8419266A0 (it) Tessuti del corpo umano e dispositivo per generare calore in procedimento di generazione dicalore, particolarmente per la cura di tumori.
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
TR200400149T2 (tr) Tümörlerin teşhisi ve tedavisi için mikroorganizmalar ve hücreler
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
EP1706423B8 (de) Therapeutische und diagnostische anti-hsp 70-antikörper
CY1109029T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου
WO2002014361A3 (en) NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
WO2004072263A3 (en) Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2002014501A3 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
WO2002000822A3 (en) A NOVEL POLYPEPTIDE, A HUMAIN PROTEIN SYNTHESIS INITIATION FACTOR SUB-UNIT 2 β 16.5 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
DE60230051D1 (de) Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs
WO2001075022A3 (fr) Nouveau polypeptide, eucaryon acetyl transferase humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
RU2000127063A (ru) Способ лечения дегенеративно-дистрофических поражений позвоночника у детей
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
ATE65543T1 (de) Dna-sequenzen des ebv-genoms, rekombinante dnamolek¨le, verfahren zur herstellung von ebvverwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1311675

Country of ref document: EP